We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA has announced that black box labeling for Danco Laboratories’ Mifeprex will be revised to reflect serious complications in patients taking the drug, including at least two deaths.